nonprofit logo

Americas Committee For Treatment And Research In Multiple Sclerosis Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 264496795 ✦ Middleton, WI ✦ Designated as a 501(c)(3)

Overview

What is Americas Committee For Treatment And Research In Multiple Sclerosis Inc?

Americas Committee For Treatment And Research In Multiple Sclerosis Inc, abbreviated as ACTRIMS, is a dedicated nonprofit organization based in Middleton, Wisconsin. Their primary focus is on the treatment, research, and advancement of Multiple Sclerosis (MS) and related disorders. ACTRIMS serves as a platform for a community of leaders, fostering collaboration among various disciplines. Their mission is to construct a network that progresses the science and therapy of MS, disseminates knowledge, and promotes education in this field. In 2022, ACTRIMS organized a successful hybrid event, combining in-person participation, live streaming, and on-demand options, setting records in terms of abstracts submitted and presented, as well as attendees.


Official website here: www.actrims.org

Is Americas Committee For Treatment And Research In Multiple Sclerosis Inc legitimate?

Americas Committee For Treatment And Research In Multiple Sclerosis Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Americas Committee For Treatment And Research In Multiple Sclerosis Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


Official website here: www.actrims.org

What is the mission statement of Americas Committee For Treatment And Research In Multiple Sclerosis Inc?

The Americas Committee For Treatment And Research In Multiple Sclerosis Inc, often referred to as ACTRIMS, is dedicated to building a community that advances the science and treatment of Multiple Sclerosis (MS) and related disorders. Their mission involves fostering a community of leaders, disseminating knowledge, and promoting education in this field. ACTRIMS is committed to collaborating among various disciplines to make significant strides in the understanding and treatment of MS. In 2022, they successfully organized an in-person event, which saw a record number of abstracts, presentations, and participants, both in person and virtually. This event included live streaming and on-demand options, further enhancing its reach.


Official website here: www.actrims.org

Who is the CEO of Americas Committee For Treatment And Research In Multiple Sclerosis Inc?

Jennifer Brydges is the President of Americas Committee For Treatment And Research In Multiple Sclerosis Inc. The CEO's salary of Americas Committee For Treatment And Research In Multiple Sclerosis Inc is $0 and their total compensation is $0.


Official website here: www.actrims.org

What is the revenue of Americas Committee For Treatment And Research In Multiple Sclerosis Inc?

Americas Committee For Treatment And Research In Multiple Sclerosis Inc's revenue in 2022 was $1,998,178.


Official website here: www.actrims.org

Who are the executives of Americas Committee For Treatment And Research In Multiple Sclerosis Inc and what are their salaries?

Here are 16 key members and their salaries (Americas Committee For Treatment And Research In Multiple Sclerosis Inc's CEO's salary is $0 and their total compensation is $0):

    Mark Freedman Md (President) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Emmanuelle Waubant Md (President-Elect) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Robert Naismith Md (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Benjamin Segal Md (Secretary) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jeffrey Cohen Md (Past President) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Tanuja Chitnis Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Alexandre Prat Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Fiona Costello Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Myla Goldman Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Daniel Reich Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Catherine Larochelle (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Erin Longbrake (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Daniel Ontaneda (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • V Wee Yong (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jennifer Brydges (Managing Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Lynda Patterson Fasae Cae (Chief Executive Officer)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.actrims.org

    Where can I find the form 990 for Americas Committee For Treatment And Research In Multiple Sclerosis Inc?

    The Americas Committee For Treatment And Research In Multiple Sclerosis Inc’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.actrims.org

    Learn more at the official website: www.actrims.org

    Mission Statement of Americas Committee For Treatment And Research In Multiple Sclerosis Inc

    The Americas Committee For Treatment And Research In Multiple Sclerosis Inc, often referred to as ACTRIMS, is a community of dedicated professionals with a mission to advance the scientific understanding and treatment of Multiple Sclerosis (MS) and related disorders. Their primary objective is to build a collaborative network that brings together various disciplines, fostering knowledge dissemination and education in the field. By doing so, ACTRIMS aims to make significant strides in the fight against MS, a debilitating neurological disorder. In 2022, ACTRIMS demonstrated its commitment to this mission by hosting a successful in-person event. This event saw an influx of abstracts, presentations, and participants, breaking previous records. The event was a hybrid one, offering both live streaming and on-demand options, in addition to in-person participation, further expanding its reach and accessibility.

    Impact

    This information is meant to be a general summary of Americas Committee For Treatment And Research In Multiple Sclerosis Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    Americas Committee For Treatment And Research In Multiple Sclerosis Inc, also known as ACTRIMS, has a significant impact on the treatment and research of multiple sclerosis. In 2022, ACTRIMS organized a highly successful in-person event that broke records in terms of abstracts received and presented, as well as the number of participants attending both in person and virtually. This event featured additional programming and offered live streaming and on-demand options, making it a truly hybrid and inclusive experience.

    ACTRIMS is a community of leaders dedicated to advancing the science and treatment of multiple sclerosis and related disorders. Their mission is to build a community that fosters collaboration among disciplines, disseminates knowledge, and promotes education in the field of MS research and treatment. Through their activities and initiatives, ACTRIMS plays a crucial role in advancing the understanding and management of multiple sclerosis, ultimately benefiting individuals affected by this condition.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $402,107
  • Program Service Revenue: $529,922
  • Gross Receipts: $2,521,527

    • Assets and Liabilities:
  • Total Assets: $9,333,800
  • Total Liabilities: $138,300
  • Net Assets: $9,195,500
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    MEETING REVENUE

    Revenue

    $529,922

    Organization Details

    Founding Year

    2009

    Principal Officer

    Jennifer Brydges

    Main Address

    1818 PARMENTER ST 300, MIDDLETON, WI, 535623170

    NTEE Category

    Code: P20 - Human services

    If you are a representative of Americas Committee For Treatment And Research In Multiple Sclerosis Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.